Streetbeat News

Analyst Ratings

AMP

In the past three months, four analysts have rated Ameriprise Financial (NYSE:AMP) with varying perspectives. The average 12-month price target has increased by 3.38% to $488.75. Analysts have adjusted their ratings and price targets, reflecting their views on the company's market position and financial performance.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 7:11 pm

AVGO

Cantor Fitzgerald has maintained an Overweight rating on Broadcom (NASDAQ:AVGO) and raised its price target from $200 to $225, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 7:11 pm

WAY

Analysts have varied opinions on Waystar Holding (NASDAQ:WAY), with recent ratings showing a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased to $29.6, reflecting a 13.85% rise from the previous target. Analysts have raised their ratings and price targets, indicating positive expectations for the company's performance.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 7:11 pm

SBUX

Citigroup analyst Jon Tower maintains a Neutral rating on Starbucks and raises the price target from $98 to $99.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 7:11 pm

UGRO

Small Cap Consumer Research analyst Eric Beder has reiterated a Buy rating on Urban-gro (NASDAQ:UGRO) and maintained a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 7:11 pm

HLI

Houlihan Lokey (NYSE:HLI) has received mixed analyst ratings over the past three months, with a recent increase in bullish sentiment. The average 12-month price target has risen to $154.22, with a high of $190.00 and a low of $129.00. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Houlihan Lokey has shown strong financial metrics, including a 23.51% revenue growth rate, a net margin of 17.32%, and a debt-to-equity ratio of 0.24.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 7:00 pm

ZYXI

RBC Capital analyst Shagun Singh maintains an Outperform rating on Zynex (NASDAQ:ZYXI) but lowers the price target from $12 to $11.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:58 pm

ZBH

RBC Capital analyst Shagun Singh maintains an Outperform rating on Zimmer Biomet Holdings but lowers the price target from $130 to $120.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:57 pm

TFX

RBC Capital analyst Shagun Singh maintains an Outperform rating on Teleflex (NYSE:TFX) and raises the price target from $260 to $275.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:56 pm

PEN

RBC Capital analyst Shagun Singh has maintained an 'Outperform' rating on Penumbra (NYSE:PEN) and increased the price target from $205 to $222.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:54 pm